The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Mar 2014 14:22

INTERSERVE PLC - Holding(s) in Company

INTERSERVE PLC - Holding(s) in Company

PR Newswire

London, March 21

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying Interserve Plcissuer of existing shares to which votingrights are attached: ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes An acquisition or disposal of qualifying financial instruments which Nomay result in the acquisition of shares already issued to which votingrights are attached An acquisition or disposal of instruments with similar economic effect Noto qualifying financial instruments An event changing the breakdown of voting rights Yes Other (please Nospecify): 3. Full name of person(s) subject to Standard Life Investments Ltdthe notification obligation: iii 4. Full name of shareholder(s) (if Vidacos Nomineesdifferent from 3.):iv 5. Date of the transaction and date 20 March 2014on which the threshold is crossed orreached: v 6. Date on which issuer notified: 21 March 2014 7. Threshold(s) that is/are crossed 8%or reached: vi, vii 8. Notified details:A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation aftershares to the triggering the triggering transaction transaction if possible Number Number Number Number of % of votingusing of of of shares voting rights xthe ISIN CODE Shares Voting rights Rights Direct Direct xi Indirect Direct Indirect xii GB0001528156 11,233,661 11,233,661 11,768,009 3,459,651 8,308,358 2.436% 5.850% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period rights that may be rights xiv acquired if the instrument is exercised/ con verted. C: Financial Instruments with similar economic effect to Qualifying FinancialInstruments xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date xvii Conversion rights instrument rights xix, xx instrument period refers to xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 11,768,009 8.285% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy N/Aholder will cease to hold: 12. Date on which proxy holder will N/Acease to hold voting rights: 13. Additional information: N/A 14. Contact name: Mr Trevor Bradbury 15. Contact telephone number: 0118 932 0123
Date   Source Headline
23rd Jun 20179:20 amRNSHolding(s) in Company
20th Jun 20173:51 pmRNSHolding(s) in Company
20th Jun 20177:00 amRNSInterserve announces contract win
19th Jun 201712:24 pmRNSHolding(s) in Company
14th Jun 20174:04 pmRNSHolding(s) in Company
14th Jun 20171:55 pmRNSHolding(s) in Company
13th Jun 201711:00 amRNSHolding(s) in Company
9th Jun 20172:19 pmRNSDirector/PDMR Shareholding
12th May 20173:04 pmRNSResult of AGM
12th May 20177:00 amRNSAGM Trading Update
9th May 20173:45 pmRNSDirector/PDMR Shareholding
24th Apr 201712:45 pmRNSHolding(s) in Company
24th Apr 20177:00 amRNSInterserve wins £36.5 million contract
18th Apr 20173:08 pmRNSDirector/PDMR Shareholding - Correction
12th Apr 20172:34 pmRNSDirector/PDMR Shareholding
7th Apr 201711:49 amRNSDirector/PDMR Shareholding
30th Mar 20179:01 amRNSPublication of Annual Report 2016
22nd Mar 20179:49 amRNSHolding(s) in Company
14th Mar 20178:44 amRNSHolding(s) in Company
10th Mar 201710:00 amRNSDirector/PDMR Shareholding
9th Mar 201712:27 pmRNSHolding(s) in Company
8th Mar 20179:12 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSDebbie White appointed as Chief Executive Officer
6th Mar 20172:48 pmRNSHolding(s) in Company
6th Mar 20172:47 pmRNSHolding(s) in Company
3rd Mar 20179:27 amRNSHolding(s) in Company
28th Feb 20177:00 amRNSFinal Results
20th Feb 20177:00 amRNSEnergy from Waste Update
10th Feb 201711:29 amRNSDirector/PDMR Shareholding
6th Feb 20177:00 amRNSContract Win
11th Jan 20177:00 amRNSBoard Appointment
11th Jan 20177:00 amRNSTrading Update
10th Jan 20171:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSBlock listing Interim Review
9th Dec 20163:20 pmRNSDirector/PDMR Shareholding
15th Nov 20161:00 pmRNSEnergy from Waste Update
14th Nov 20162:16 pmRNSTrading Update
14th Nov 20162:15 pmRNSBoard Change
14th Nov 20167:00 amRNSContract Win
9th Nov 201612:17 pmRNSDirector/PDMR Shareholding
31st Oct 201610:31 amRNSDirector/PDMR Shareholding
21st Oct 201611:18 amRNSHolding(s) in Company
19th Oct 20167:00 amRNSInterserve hosts capital markets day in London
17th Oct 20167:00 amRNSContract Win
12th Oct 201611:59 amRNSDirector/PDMR Shareholding
10th Oct 20167:00 amRNSConclusion of Strategic Review
3rd Oct 20167:00 amRNSContract Win
27th Sep 20167:00 amRNSPlace on department of health's £4BN P22 framework
21st Sep 20167:00 amRNSInterserve JV wins £81m UAE mall contract
19th Sep 20167:00 amRNS£11 million environment agency contract extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.